English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  53242093    Online Users :  725
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"shang gin wu"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 21-61 of 61  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-08-12T08:25:30Z Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection Yang P.-C.; Kuo P.-H.; Wu J.-Y.; SHANG-GIN WU; Sun H.-Y.
臺大學術典藏 2020-08-12T08:25:29Z Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor Chang T.-H.; Tsai M.-F.; Su K.-Y.; SHANG-GIN WU; Huang C.-P.; Yu S.-L.; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:29Z Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis Wu S.-J.; Tsai T.-H.; Shang-Gin Wu ;Tsai T.-H. ;Wu S.-J.; SHANG-GIN WU
臺大學術典藏 2020-08-12T08:25:28Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.;Shang-Gin Wu;Chang Y.-L.;Wu C.-T.;Tsai M.-F.;Wei P.-F.;Yang C.-H.;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:28Z Pericardial pigtail knotting Shang-Gin Wu ;Shih J.-Y.; SHANG-GIN WU; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:28Z Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction Shang-Gin Wu ;Chang Y.-L. ;Lin J.-W. ;Wu C.-T. ;Chen H.-Y. ;Tsai M.-F. ;Lee Y.-C. ;Yu C.-J. ;Shih J.-Y.; SHANG-GIN WU; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:27Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR SHANG-GIN WU; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:26Z Survival of lung adenocarcinoma patients with malignant pleural effusion Shang-Gin Wu;Yu C.-J.;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; SHANG-GIN WU; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:26Z Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; SHANG-GIN WU
臺大學術典藏 2020-08-12T08:25:26Z Brain metastasis in NSCLC patients: Mechanism, diagnosis and treatment Shih J.-Y.; SHANG-GIN WU; Shang-Gin Wu;Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:25Z Brain Metastasis of Patients with Lung Adenocarcinoma: Epidermal Growth Factor Receptor Mutations and Response to Whole-Brain Radiation Therapy Shih J.-Y.; SHANG-GIN WU
臺大學術典藏 2020-08-12T08:25:25Z Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case Gow C.-H.; SHANG-GIN WU; Chang Y.-L.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:25Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; SHANG-GIN WU; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.
臺大學術典藏 2020-08-12T08:25:24Z Treatment outcome of patients with isoniazid mono-resistant tuberculosis Yu C.-J.; Chien J.-Y.; Chen Y.-T.; SHANG-GIN WU; Lee J.-J.; Wang J.-Y.
臺大學術典藏 2020-08-12T08:25:24Z IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer Chen H.-Y.; Yu S.-L.; Yang J.C.-H.; Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Tsai M.-F.; Chang T.-H.; Liu Y.-N.
臺大學術典藏 2020-08-12T08:25:24Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; SHANG-GIN WU; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:23Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients SHANG-GIN WU; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:23Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Chen Y.-F.; Hsieh M.-S.; SHANG-GIN WU; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.; Chen Y.-F.;Hsieh M.-S.;Shang-Gin Wu;Chang Y.-L.;Yu C.-J.;Yang J.C.-H.;Yang P.-C.;Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:23Z EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway Shih J.-Y.; Tsai M.-F.; Chang T.-H.; SHANG-GIN WU; Yang H.-Y.; Hsu Y.-C.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:23Z Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion Tsai T.-H.;Shang-Gin Wu;Hsieh M.-S.;Yu C.-J.;Yang J.C.H.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:22Z The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition SHANG-GIN WU; Chang Y.-L.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:21Z Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C Chang T.-H.;Tsai M.-F.;Gow C.-H.;Shang-Gin Wu;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; SHANG-GIN WU; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:21Z Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer Lin Y.-T.;Liu Y.-N.;Shang-Gin Wu;Yang J.C.-H.;Shih J.-Y.; Lin Y.-T.; Liu Y.-N.; SHANG-GIN WU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:21Z A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population Gow C.-H.; Hsieh M.-S.; SHANG-GIN WU; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:20Z Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer Shang-Gin Wu;Shih J.-Y.; SHANG-GIN WU; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:19Z IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer Shang-Gin Wu;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Shih J.-Y.; SHANG-GIN WU; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:18Z MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process Wang H.-Y.;Liu Y.-N.;Shang-Gin Wu;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Shih J.-Y.; Wang H.-Y.; Liu Y.-N.; SHANG-GIN WU; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:17Z Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer Lin Y.-T.;Tsai T.-H.;Shang-Gin Wu;Liu Y.-N.;Yu C.-J.;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; SHANG-GIN WU; Liu Y.-N.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2019 Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer Shih J.-Y.; Chang Y.-L.; Gow C.-H.; Tsai T.-H.; Chang T.-H.; Liu Y.-N.;Tsai M.-F.;Shang-Gin Wu;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; SHANG-GIN WU
臺大學術典藏 2019 High throughput sequencing of T-cell receptor repertoire using dry blood spots Li S.; SHANG-GIN WU; Pan W.; Liu H.; Byrne-Steele M.L.; Brown B.; Depinet M.; Hou X.; Han J.
臺大學術典藏 2019 MicroRNA in lung cancer metastasis Shang-Gin Wu;Chang T.-H.;Liu Y.-N.;Shih J.-Y.; SHANG-GIN WU; Chang T.-H.; Liu Y.-N.; Shih J.-Y.
臺大學術典藏 2018 Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Liu Y.-N.; SHANG-GIN WU; Shang-Gin Wu;Liu Y.-N.;Yu C.-J.;Yang J.C.-H.;Shih J.-Y.
臺大學術典藏 2016 Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma SHANG-GIN WU; Liu Y.-N.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2013 Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas SHANG-GIN WU; Lin C.-H.; Cheng A.-L.; Lu Y.-S.; Shih J.-Y.; Yang J.C.-H.; Huang W.-C.; Wu P.-F.
臺大學術典藏 2012 Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Chung K.-P.;Shang-Gin Wu;Wu J.-Y.;Yang J.-H.;Yu C.-J.;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; SHANG-GIN WU; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2012 RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C.; SHANG-GIN WU; Su K.-Y.; Tsai T.-H.
中國醫藥大學 2011-04 Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. (Tzu-Hua Chan); (Meng-Feng Tsai); (Kang-Yi Su); (Shang-Gin Wu); (Cheng-Po Huang); (Sung-Liang Yu); 余永倫(Yung-Luen Yu); (Chou-Chin Lan); (Chih-Hsin Yang); (Shwu-Bin Lin); (Chin-Pyng Wu); (Jin-Yuan Shih); (Pan-Chyr Yang)*
臺大學術典藏 2011 Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Shang-Gin Wu ;Yang C.-H. ;Yu C.-J. ;Lee J.-H. ;Hsu Y.-C. ;Chang Y.-L. ;Shih J.-Y. ;Yang P.-C.; SHANG-GIN WU; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2011 Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Yang P.-C.; Shih J.-Y.; Hsu Y.-C.; Chang Y.-C.; Chang Y.-L.; Yang C.-H.; SHANG-GIN WU; Wu J.-Y.
臺大學術典藏 2010 Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation Kuo Y.-W.; SHANG-GIN WU; Ho C.-C.; Shih J.-Y.
臺大學術典藏 2008 Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma SHANG-GIN WU; Gow C.-H.; Yu C.-J.; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C.

Showing items 21-61 of 61  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page